By Justin Petrone

Agilent Technologies continues to see strong demand for its life science research tools, including microarrays, which contributed to a 39 percent increase in second-quarter revenues for the company's Life Sciences business while company-wide sales rose 32 percent.

CEO Bill Sullivan said the firm saw "solid growth" in second-quarter sales of liquid chromatographers, mass spectrometers, microarrays, automation tools, and informatics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.